Pfizer To Settle Celebrex, Bextra Suits For $894M
Drugmaker Pfizer Inc. has agreed to pay $894 million to settle the bulk of product liability, consumer fraud and state attorney general lawsuits filed against it over anti-inflammatory drugs Celebrex and...To view the full article, register now.
Already a subscriber? Click here to view full article